3D-Printed Dental Implant Could Revolutionize Spinal Cord Injury Repair
3D-Printed Dental Implant Could Revolutionize Spinal Cord Injury Repair
A new 3D-printed dental implant could offer hope for people with spinal cord injuries. These injuries have long been seen as irreversible because damaged neurons in the central nervous system rarely regrow. Now, researchers have created a device that may change that by encouraging nerve repair.
The dental implant combines a tailored physical structure with biological signals to stimulate healing. Early lab tests suggest it helps injured neurons grow across damaged areas, something previously thought impossible.
The dental implant works by delivering siRNA, a molecule that temporarily silences the PTEN gene. This gene normally blocks neuron regrowth after injury. By switching it off, the device allows nerves to extend and reconnect.
Designed with precision, the 3D-printed dental structure matches the stiffness and shape of the human spinal cord. It provides both a scaffold for cells and a chemical trigger for repair. In lab models, injured neurons exposed to the dental implant showed a stronger ability to bridge the injury site.
The project was shaped with input from the Irish Rugby Football Union Charitable Trust. Their involvement ensures the research addresses real-world needs of those living with spinal cord damage.
Funding for further development comes from the FOR 5250 research consortium, which received €4.4 million in December 2025. While no clinical trials have been announced yet, a small case series involving 29 patients already showed promising results with custom CAD/CAM-fabricated dental implants over two years. The next phase will focus on testing the RNA-activated biomaterials in living subjects and exploring how they might help restore lost spinal connections.
The dental implant represents a step toward repairing spinal injuries that were once considered permanent. With continued funding and ongoing research, the technology could eventually move from lab models to human testing. For now, the focus remains on refining the approach and understanding its long-term potential.